Jin Iljung, Nam Hojung
School of Electrical Engineering and Computer Science, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
AI Graduate School, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
J Chem Inf Model. 2021 Aug 23;61(8):3858-3867. doi: 10.1021/acs.jcim.1c00706. Epub 2021 Aug 3.
Understanding differences in drug responses between patients is crucial for delivering effective cancer treatment. We describe an interpretable AI model for use in predicting drug responses in cancer cells at the gene, molecular pathway, and drug level, which we have called the hierarchical network for drug response prediction with attention. We found that the model shows better accuracy in predicting drugs having efficacy against a given cell line than other state-of-the-art methods, with a root mean squared error of 1.0064, a Pearson's correlation coefficient of 0.9307, and an value of 0.8647. We also confirmed that the model gives high attention to drug-target genes and cancer-related pathways when predicting a response. The validity of predicted results was proven by in vitro cytotoxicity assay. Overall, we propose that our hierarchical and interpretable AI-based model is capable of interpreting intrinsic characteristics of cancer cells and drugs for accurate prediction of cancer-drug responses.
了解患者之间药物反应的差异对于提供有效的癌症治疗至关重要。我们描述了一种可解释的人工智能模型,用于在基因、分子途径和药物水平上预测癌细胞中的药物反应,我们将其称为具有注意力机制的药物反应预测分层网络。我们发现,与其他现有方法相比,该模型在预测对给定细胞系有效的药物时表现出更高的准确性,均方根误差为1.0064,皮尔逊相关系数为0.9307, 值为0.8647。我们还证实,该模型在预测反应时高度关注药物靶点基因和癌症相关途径。体外细胞毒性试验证明了预测结果的有效性。总体而言,我们提出,我们基于人工智能的分层可解释模型能够解释癌细胞和药物的内在特征,以准确预测癌症药物反应。